HypnoDA: HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers
Study Details
Study Description
Brief Summary
Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No Intervention: Therapeutic education program
|
|
| Experimental: Therapeutic education program and Hypnosis
|
Behavioral: Hypnosis
The experimental group will receive 2 standardized hypnosis sessions via the "superhero costume" technique performed during this collective therapeutic education program, completed by a reinforcement through the practice of self-hypnosis at home guided by the listening of an audio recording
|
Outcome Measures
Primary Outcome Measures
- Patient Recruitment [24 months]
Evaluate the patient recruitment rate in a pilot, randomized controlled study proposing a hypnosis program to children with moderate to severe AD.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Children aged 8 to 17 years
-
Understanding french
-
With moderate to severe AD clinically diagnosed by a physician (SCORing Atopic Dermatitis (SCORAD) ≥ 25)
-
Referred by their referring physician in the Reunionese therapeutic education program for AD provided within the atopy school of the Reunion University Hospital. - Oral consent of the child and of one of the legal representatives collected.
Exclusion Criteria:
-
Children refusing to participate in the hypnosis session
-
Not having the possibility to listen to an audio file,
-
Already practicing self-hypnosis for their AD before inclusion,
-
Having a contraindication to hypnosis (psychiatric disorders, psychosis)
-
Treated by a systemic treatment for their AD.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU de la Réunion | Saint-Denis | Réunion | 97400 |
Sponsors and Collaborators
- Centre Hospitalier Universitaire de la Réunion
Investigators
- Principal Investigator: Juliette MIQUEL, MD, CHU de la Réunion
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2022/CHU/15